Please assess the completion status of the following clinical trial:

Trial Title: Solving Insomnia Electronically: Sleep Treatment for Asthma

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Age 18-75 years~2. Telephone, email address, reliable Internet access~3. Have a current primary care physician or a physician who is managing patient's asthma~4. Diagnosis of asthma supported by at least one of the following:~   1. Patient self-report of physician diagnosis of asthma~  2. Asthma diagnosis in the electronic medical record~5. Self-report of current use of medications for asthma~6. FEV1 of ≥ 45% of the predicted normal value for the patient, after withholding bronchodilators at or personal best peak expiratory flow of \> 100 L/min~7. Not well-controlled asthma: Score 12-19 on Asthma Control Test for those on an inhaled corticosteroid; Score 16-19 on Asthma Control Test for those not on an inhaled corticosteroid.~8. Impaired asthma-specific quality of life: Score ≤ 5 on Asthma Quality of Life Questionnaire~9. If subjects are on a controller medication (i.e., inhaled corticosteroid, inhaled corticosteroid and long acting beta-agonists, Singulair, etc.), they must be on stable doses and schedules (i.e., unchanged) of therapy for 2 months prior to enrollment.~10. Meets criteria for DSM-5 Insomnia Disorder~11. At least moderate insomnia severity: Score \> 7 on Insomnia Severity Index~12. Stable self-reported medical, psychiatric conditions~Exclusion Criteria:~1. Non-English speaking, illiterate, or sensory deficits~2. Plans to move or leave present source of care during the following 8 months~3. Receiving antibiotics for upper respiratory infection or pulmonary condition in previous 2 weeks~4. Heavy smoking: Age \< 30 years and smoking history \> 10 pack years OR age ≥ 30 and smoking history \> 15 pack years OR smoking within previous 12 months~5. Substance abuse disorder within previous 3 months~6. Self-reported cystic fibrosis, COPD or interstitial lung disease~7. Self-report of \> 3 asthma attacks/exacerbations requiring systemic corticosteroids, emergency room visit, or hospitalization within the previous year~8. Oral corticosteroid dosage of \> 10 mg/daily~9. Poorly controlled gastroesophageal reflux disease (GERD)~10. Untreated severe obstructive sleep apnea based on apnea-hypopnea index of ≥ 55~11. Self-reported untreated restless legs syndrome~12. History of bipolar disorder or psychosis~13. Current major depression or active suicidal ideation.~14. Asthma attacks/exacerbations requiring systemic corticosteroids, emergency room visit, or hospitalization within the previous 4 weeks~15. Self-report of current pregnancy or trying to become pregnant. Participants who become pregnant during course of the study will be withdrawn from the study.~16. Shift work that includes working the night shift (between the hours of 12:00 a.m. - 6:00 a.m.)~17. Enrolled in prior R03 study (HL135213)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- SHUTi (Type: EXPERIMENTAL): Self-guided, automated, interactive, and tailored web-based program
- Emmi (Type: EXPERIMENTAL): A program that is an animated online video that walks patients through important information about a health topic, condition or procedure.

Based on this trial design, predict the completion outcome and termination type (if applicable).